# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 17, "Acta Ophthalmol .", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasJournal> \"Acta Ophthalmol .\"."
1, PublicationYear, 18, 22, "2008", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasPublicationYear> \"2008\"."
2, Title, 124, 285, "Efficacy and safety of latanoprost versus pilocarpine / timolol maleate fixed combination in patients with primary open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasTitle> \"Efficacy and safety of latanoprost versus pilocarpine / timolol maleate fixed combination in patients with primary open - angle glaucoma or ocular hypertension .\"."
3, Latanoprost, 147, 158, "latanoprost", "", "<http://ctro/data#Latanoprost_71270> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Latanoprost>. <http://ctro/data#Medication_71269> <http://ctro/data#hasDrug> <http://ctro/data#Latanoprost_71270>."
4, Pilocarpine, 166, 177, "pilocarpine", "", 
92, Pilo/TimFC, 166, 195, "pilocarpine / timolol maleate", "", "<http://ctro/data#Medication_71276> <http://ctro/data#hasDrug> <http://ctro/data#Pilo/TimFC>."
5, Timolol, 180, 195, "timolol maleate", "", 
38, Primary_OpenAngleGlaucoma, 231, 260, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
7, OcularHypertension, 264, 283, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
8, Author, 286, 297, "Ka ł uzny J", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Ka ł uzny J\"."
9, Author, 306, 315, "Sobecki R", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Sobecki R\"."
10, Author, 318, 340, "Czechowicz - Janicka K", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Czechowicz - Janicka K\"."
11, Author, 343, 350, "Kecik D", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Kecik D\"."
12, Author, 353, 365, "Ka ł uzny BJ", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Ka ł uzny BJ\"."
13, Author, 368, 378, "Stewart JA", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Stewart JA\"."
14, Author, 381, 391, "Stewart WC", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasAuthor> \"Stewart WC\"."
15, Poland, 478, 484, "Poland", "", "<http://ctro/data#Population_71226> <http://ctro/data#hasCountry> <http://ctro/data#Poland>."
16, ObjectiveDescription, 497, 613, "This study aimed to compare the safety and effect on intraocular pressure ( IOP ) of latanoprost given every evening", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasObjectiveDescription> \"This study aimed to compare the safety and effect on intraocular pressure ( IOP ) of latanoprost given every evening\"."
18, IOP, 550, 570, "intraocular pressure", "", 
19, IOP, 573, 576, "IOP", "", 
20, Latanoprost, 582, 593, "latanoprost", "", 
78307, Interval, 600, 613, "every evening", "", "<http://ctro/data#Intervention_71257> <http://ctro/data#hasInterval> \"every evening\"."
17, ObjectiveDescription, 614, 781, "versus pilocarpine / timolol maleate fixed combination ( PTFC ) given twice daily in patients with primary open - angle glaucoma ( POAG ) or ocular hypertension ( OH )", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasObjectiveDescription> \"versus pilocarpine / timolol maleate fixed combination ( PTFC ) given twice daily in patients with primary open - angle glaucoma ( POAG ) or ocular hypertension ( OH )\"."
23, Pilocarpine, 621, 632, "pilocarpine", "", 
108, Pilo/TimFC, 621, 650, "pilocarpine / timolol maleate", "", 
24, Timolol, 635, 650, "timolol maleate", "", 
109, Pilo/TimFC, 671, 675, "PTFC", "", 
25, Frequency, 684, 695, "twice daily", "", "<http://ctro/data#Intervention_71263> <http://ctro/data#hasFrequency> \"twice daily\"."
78313, Precondition, 699, 781, "patients with primary open - angle glaucoma ( POAG ) or ocular hypertension ( OH )", "", "<http://ctro/data#Population_71226> <http://ctro/data#hasPrecondition> \"patients with primary open - angle glaucoma ( POAG ) or ocular hypertension ( OH )\"."
39, Primary_OpenAngleGlaucoma, 713, 742, "primary open - angle glaucoma", "", 
40, Primary_OpenAngleGlaucoma, 745, 749, "POAG", "", 
26, OcularHypertension, 755, 774, "ocular hypertension", "", 
27, OcularHypertension, 777, 779, "OH", "", 
28, Randomized, 866, 876, "randomized", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
29, Placebo, 900, 907, "placebo", "", "<http://ctro/data#Medication_98630> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
78316, Interval, 921, 934, "every morning", "", "<http://ctro/data#Intervention_98637> <http://ctro/data#hasInterval> \"every morning\"."
30, Morning, 927, 934, "morning", "", 
32, Latanoprost, 939, 950, "latanoprost", "", 
34, Frequency, 951, 964, "every evening", "", 
120, Pilo/TimFC, 971, 975, "PTFC", "", 
35, Frequency, 989, 1000, "twice daily", "", 
36, Duration, 1009, 1016, "8 weeks", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasCTduration> \"8 weeks\"."
37, IOP, 1032, 1035, "IOP", "", 
78317, TimePoint, 1052, 1097, "08 . 00 , 10 . 00 , 16 . 00 and 18 . 00 hours", "", 
78318, TimePoint, 1062, 1097, "10 . 00 , 16 . 00 and 18 . 00 hours", "", 
78319, TimePoint, 1072, 1097, "16 . 00 and 18 . 00 hours", "", 
78320, TimePoint, 1084, 1097, "18 . 00 hours", "", 
124, FinalNumPatientsCT, 1231, 1243, "Thirty - two", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasFinalNumberPatientsCT> \"Thirty - two\"."
42, Diurnal_IOP, 1311, 1314, "IOP", "", "<http://ctro/data#Endpoint_71234> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
43, BaseLineValue, 1318, 1324, "24 . 1", "", "<http://ctro/data#Outcome_71283> <http://ctro/data#hasBaselineValue> \"24 . 1\". <http://ctro/data#Outcome_71310> <http://ctro/data#hasBaselineValue> \"24 . 1\"."
127, SdDevBL, 1331, 1336, "2 . 4", "", "<http://ctro/data#Outcome_71283> <http://ctro/data#hasSdDevBL> \"2 . 4\". <http://ctro/data#Outcome_71310> <http://ctro/data#hasSdDevBL> \"2 . 4\"."
45, mmHg, 1337, 1341, "mmHg", "", "<http://ctro/data#Endpoint_71234> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
46, Mean, 1344, 1348, "Mean", "", "<http://ctro/data#Mean_71236> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_71234> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_71236>."
130, Diurnal_IOP, 1349, 1365, "diurnal pressure", "", 
47, ResultMeasuredValue, 1370, 1376, "16 . 8", "", "<http://ctro/data#Outcome_71310> <http://ctro/data#hasResultMeasuredValue> \"16 . 8\"."
133, SdDevResValue, 1383, 1388, "2 . 1", "", "<http://ctro/data#Outcome_71310> <http://ctro/data#hasSdDevResValue> \"2 . 1\"."
51, mmHg, 1389, 1393, "mmHg", "", 
136, Pilo/TimFC, 1397, 1401, "PTFC", "", 
48, ResultMeasuredValue, 1406, 1412, "16 . 9", "", "<http://ctro/data#Outcome_71283> <http://ctro/data#hasResultMeasuredValue> \"16 . 9\"."
134, SdDevResValue, 1419, 1424, "2 . 5", "", "<http://ctro/data#Outcome_71283> <http://ctro/data#hasSdDevResValue> \"2 . 5\"."
52, mmHg, 1425, 1429, "mmHg", "", 
53, Latanoprost, 1433, 1444, "latanoprost", "", 
139, PvalueDiff, 1449, 1457, "= 0 . 60", "", "<http://ctro/data#DiffBetweenGroups_71337> <http://ctro/data#hasPvalueDiff> \"= 0 . 60\"."
78341, ObservedResult, 1462, 1519, "No statistical difference between treatments was observed", "", "<http://ctro/data#Outcome_71441> <http://ctro/data#hasObservedResult> \"No statistical difference between treatments was observed\"."
78342, TimePoint, 1523, 1550, "any individual time - point", "", "<http://ctro/data#Outcome_71441> <http://ctro/data#hasTimePoint> \"any individual time - point\"."
78327, TimePoint, 1561, 1574, "10 . 00 hours", "", "<http://ctro/data#Outcome_71346> <http://ctro/data#hasTimePoint> \"10 . 00 hours\". <http://ctro/data#Outcome_71373> <http://ctro/data#hasTimePoint> \"10 . 00 hours\"."
141, Pilo/TimFC, 1586, 1590, "PTFC", "", 
60, IOP, 1613, 1616, "IOP", "", 
61, ResultMeasuredValue, 1620, 1626, "15 . 9", "", "<http://ctro/data#Outcome_71373> <http://ctro/data#hasResultMeasuredValue> \"15 . 9\"."
145, SdDevResValue, 1633, 1638, "2 . 3", "", "<http://ctro/data#Outcome_71373> <http://ctro/data#hasSdDevResValue> \"2 . 3\"."
63, mmHg, 1639, 1643, "mmHg", "", 
64, Latanoprost, 1648, 1659, "latanoprost", "", 
65, ResultMeasuredValue, 1660, 1666, "16 . 8", "", "<http://ctro/data#Outcome_71346> <http://ctro/data#hasResultMeasuredValue> \"16 . 8\"."
146, SdDevResValue, 1673, 1678, "2 . 7", "", "<http://ctro/data#Outcome_71346> <http://ctro/data#hasSdDevResValue> \"2 . 7\"."
67, mmHg, 1679, 1683, "mmHg", "", 
149, PvalueDiff, 1688, 1696, "= 0 . 02", "", "<http://ctro/data#DiffBetweenGroups_71400> <http://ctro/data#hasPvalueDiff> \"= 0 . 02\"."
71, ObservedResult, 1701, 1753, "There were no statistical differences between groups", "", "<http://ctro/data#Outcome_71414> <http://ctro/data#hasObservedResult> \"There were no statistical differences between groups\"."
78335, EndPointDescription, 1757, 1802, "unsolicited systemic or ocular adverse events", "", "<http://ctro/data#EndPointDescription_71410> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_71409> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_71410>."
150, PvalueDiff, 1807, 1815, "> 0 . 05", "", 
151, Pilo/TimFC, 1834, 1838, "PTFC", "", 
73, Latanoprost, 1900, 1911, "latanoprost", "", 
92867, BlurredVison, 1993, 2007, "blurred vision", "", 
163, Stinging, 2010, 2018, "stinging", "", 
78340, EndPointDescription, 2023, 2034, "ocular pain", "", 
155, Pilo/TimFC, 2040, 2044, "PTFC", "", 
165, PvalueDiff, 2049, 2058, "< 0 . 001", "", 
82, ConclusionComment, 2077, 2158, "Both PTFC and latanoprost are efficacious in reducing diurnal IOP in POAG or OH .", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasConclusionComment> \"Both PTFC and latanoprost are efficacious in reducing diurnal IOP in POAG or OH .\"."
156, Pilo/TimFC, 2082, 2086, "PTFC", "", 
78, Latanoprost, 2091, 2102, "latanoprost", "", 
79, Diurnal_IOP, 2131, 2142, "diurnal IOP", "", 
80, Primary_OpenAngleGlaucoma, 2146, 2150, "POAG", "", 
81, OcularHypertension, 2154, 2156, "OH", "", 
168, ConclusionComment, 2159, 2280, "However , PTFC may be more effective in the late morning and may have a greater incidence of mild ocular side - effects .", "", "<http://ctro/data#ClinicalTrial_71207> <http://ctro/data#hasConclusionComment> \"However , PTFC may be more effective in the late morning and may have a greater incidence of mild ocular side - effects .\"."
157, Pilo/TimFC, 2169, 2173, "PTFC", "", 
84, Morning, 2208, 2215, "morning", "", 
85, PMID, 2341, 2349, "18721251", "", "<http://ctro/data#Publication_71194> <http://ctro/data#hasPMID> \"18721251\"."
